Search - tctmd.com

Displaying 1 - 2 of 2

Sort: Relevancy | Date

Two FOURIER Subgroup Analyses Show Added Benefit of Evolocumab in Those With PAD, Prior MI

News Conference News AHA 2017

Two FOURIER Subgroup Analyses Show Added Benefit of Evolocumab in Those With PAD, Prior MI

Yael L. Maxwell

November 13, 2017

Impella Has Some Benefits in High-Risk PCI, but Clinical Impact Still Uncertain: Review

News Daily News

Impella Has Some Benefits in High-Risk PCI, but Clinical Impact Still Uncertain: Review

October 02, 2017

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.